InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Engelhart James, Chief Financial Officer. Officer active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 6 reports have been logged. Activity tracked since 25 November 2021. The latest transaction was disclosed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
3,750 shares0Common SharesSEC:0001562180-22-000353
3,750 shares0Common SharesSEC:0001562180-22-000353:0
35,000 shares0Common SharesSEC:0001562180-21-007628:0
35,000 shares0Common SharesSEC:0001562180-21-007628
3,700 shares0Common SharesSEC:0001562180-21-007300:0
3,700 shares0Common SharesSEC:0001562180-21-007300
6 of 6 declarations
About Engelhart James
Engelhart James is the Chief Financial Officer and Strategic Advisor at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees financial operations and contributes to the growth strategy of the company. His expertise in finance and risk management is essential for ensuring the financial health and sustainability of Biohaven.
